Abstract
Traditionally, #cancerpatients are considered poorly suitable for
treatment in intensive care units (ICU)[1-7]. In numerous reported
studies, ICU and hospital mortality rates were highly above average
Tremblay, Hyland et al. [8]. For stem cell recipients, data from
the 1990s showed mortality rates up to 90% Epner, White et al.
[4]. Therefore, many #clinicians remain skeptical regarding the
admission of cancer patients to intensive care units. Because of
their potentially curable disease and higher overall survival rates,
admission barriers to patients with hematologic malignancies
have been recently eased, but for stem cell recipients as well as
for patients with metastatic cancer admissions remain highly
restrictive. Over the last decade, cancer survivorship has been
qualitatively and quantitatively improved. This can be explained
through better therapies and improved management of supportive
care. Patients with #hematologicmalignancies did in particular profit
from enhanced infectious and sepsis management, but with rising
age and multi-morbid patient collectives the absolute number of
#sepsis death cases doubled National Collaborating Centre for.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.